Figure 1. Oncoprint of the Study Cohort by Pathologic Stage With Annotated Clinicopathologic Variables.

Genes are grouped by biological relevance in lung adenocarcinoma. FGA indicates fraction of genome altered; LVI, lymphovascular invasion; Mut/Mb, mutations per megabase; STAS, spread through air spaces; and TMB, tumor mutation burden.

^aP < .05, false-discovery rate, for difference in alteration frequency between stages using Fisher exact test.